Intermittent Ropivacaine Bolus for Epidural Labor Analgesia (OptimEpi)

July 4, 2019 updated by: Philippe Cuvillon, Pierre and Marie Curie University

Intermittent Bolus Administration of Ropivacaine for Epidural Labor Analgesia : an Observational Study

Enhanced patient safety and satisfaction have contributed to growing use of epidural labor analgesia. Epidural analgesia appears to be currently the most effective technique in reducing pain during labor. However, reduction in total dose of local anesthetic and thus motor blockade is crucial to improve the obstetric outcome. This technique has evolved from intermittent boluses by anesthesiologists to the current standard labor epidural analgesic regimens in many institutions in North America and Europe that consist of a local anesthetic in combination with an opioid delivered via continuous epidural infusion (CEI) with or without patient-controlled epidural analgesia (PCEA) boluses. Recently,a new mode of administration has been used: regular bolus of low concentration local anesthetic + intermittent bolus (PIEB). This technique would offer safe and superior quality labor analgesia and greater maternal satisfaction by reducing total amount of the drug combination.

The primary outcome was to evaluate the analgesic efficacy of PIEB epidural drug delivery in terms of visual analogue scale satisfaction (VAS) score in a large cohort of patients. The secondary outcomes were to measure the degree of motor blockade, neonatal and obstetric outcomes, total drug dose and incidence of pain that required top-up administration (breakthrough pain)

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Patients were explained about the procedure and written informed consent was obtained. Healthy term primi or second gravid parturients (aged >18 years) with a singleton, live fetus in vertex presentation when in active stage of labor with cervical dilation of 3-5 cm were recruited in the study after they requested epidural for pain relief. PIEB epidural analgesia was used.

Primary outcome was maternal satisfaction during labor and delivery. Our hypothesis was that patients would have a greater level of satisfaction when using PIEB technique. The secondary outcomes were to measure the degree of motor blockade, neonatal and obstetric outcomes.

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nimes, Gard, France, 30000
        • CHU Nîmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

healthy term primi or second gravid parturients aged 18-30 years with a singleton, live fetus in vertex presentation when in active stage of labor with cervical dilation of 3-5 cm

Description

Inclusion Criteria:

  • healthy term primi or second gravid parturients
  • aged 18-30 years
  • singleton, live fetus
  • vertex presentation
  • active stage of labor with cervical dilation of 3-5 cm parturients

Exclusion Criteria:

  • Hypertension
  • no vertex presentation
  • contraindications to neuraxial blockade

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Epidural group
Epidural : automatic intermittent boluses ( 8-12 mL per hour) + patient controlled bolus (4 mL evrey 20 min) using ropivacaine
Epidural : automatic intermittent boluses associated with patient controlled bolus using ropivacaine
Other Names:
  • ropivacaine 2 mg/ml

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Verbal Analogue Satisfaction Score
Time Frame: 1 day
VASS: 0-10: 0 = no satisfaction to 10 (total satisfaction)
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
maternal hypotension
Time Frame: 1 day
Evaluation of adverse events over epidural infusion (mean arterial pressure< 65 mmHg)
1 day
Apgar score
Time Frame: 1 day

The Apgar test is done by a doctor, midwife, or nurse. The health care provider examines the baby's:

  • Breathing effort
  • Heart rate
  • Muscle tone
  • Reflexes
  • Skin color

Each category is scored with 0, 1, or 2, depending on the observed condition.

1 day
Anesthetic rescue
Time Frame: 1 day
Evaluation of the rescue performed by anesthesist over infusion
1 day
nausea
Time Frame: 1 day
Number of maternal nausea event
1 day
fetal heart rate
Time Frame: 1 day
Fetal heart sounds were monitored with a continuous Doppler machine
1 day
Motor blockade
Time Frame: 1 day
Bromage score for maternal motor block
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (ACTUAL)

July 1, 2016

Study Completion (ACTUAL)

July 4, 2019

Study Registration Dates

First Submitted

May 31, 2016

First Submitted That Met QC Criteria

June 18, 2016

First Posted (ESTIMATE)

June 22, 2016

Study Record Updates

Last Update Posted (ACTUAL)

July 8, 2019

Last Update Submitted That Met QC Criteria

July 4, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Ropivacaine

3
Subscribe